Adverse events led to treatment discontinuation in six patients (5.9%) and were primarily gastrointestinal disorders (four patients experienced six AEs); there was one occurrence each of extradural haematoma, increased alanine aminotransferase, and paraesthesia that led to discontinuation (two patients experienced three AEs). Here, GPT is linked to digestive system disorder.